Literature DB >> 20155689

Chondrosarcoma of the arytenoid cartilage.

Sohit P Kanotra1, Sonika Kanotra, J Paul, Padam S Jamwal.   

Abstract

Chondrosarcoma is the most frequently encountered nonepithelial tumor of the larynx. Still, laryngeal chondrosarcoma is a rare disease, accounting for less than 1% of all laryngeal neoplasms; only about 600 cases have been reported in the world literature. The two most common sites of origin are the cricoid cartilage (69% of cases) and the thyroid cartilage (9%); arytenoid cartilage origin has been seen in less than 3% of cases. The diagnosis of laryngeal chondrosarcoma is easy to miss because of its infrequent occurrence, its indolent pattern of growth, and the difficulty in differentiating it histopathologically from chondroma. However, suspicion of arytenoid chondrosarcoma may be raised by a finding of its characteristic appearance as a smooth, hard, mucosa-covered supraglottic mass that is fairly recognizable on indirect laryngoscopy. We report a new case of chondrosarcoma of the arytenoid cartilage in a 47-year-old man, and we discuss the clinical features, diagnosis, and management of this uncommon tumor.

Entities:  

Mesh:

Year:  2010        PMID: 20155689

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  3 in total

1.  Well and intermediate differentiated laryngeal chondrosarcoma: toward conservative surgery?

Authors:  Valerio Damiani; Erika Crosetti; Giuseppe Rizzotto; Angelo Camaioni; Giovanni Succo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-23       Impact factor: 2.503

Review 2.  Clear cell chondrosarcoma of the head and neck.

Authors:  Sepideh Mokhtari; Abbas Mirafsharieh
Journal:  Head Neck Oncol       Date:  2012-04-20

3.  Chondroma of laryngeal cartilage mimicking thyroid tumor: A case report.

Authors:  ZiQiao Tan; Mengwei Yao; Tao Liu; Shaohua Wang; Jing Xu; Yonghong Zhang; Xinxin Yang; Dengdian Ma; Xiaoyu Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.